Abbott (NYSE: ABT) today the FDA approved its CardioMEMS Hero next-generation pulmonary artery (PA) pressure reader.

In November 2025, Abbott struck an agreement to acquire Exact Sciences for approximately $21 billion. Madison, Wisconsin–based Exact Sciences develops cancer screening and diagnostic tests. Its ...

The Medical Devices and Established Pharmaceuticals segments drive high single-digit growth for Abbott. Check out why ABT ...

Abbott Labs is looking to raise about $20 billion from a bond sale to help fund its acquisition of Exact Sciences, marking one of the biggest offerings this year.

Abbott Laboratories isn’t one to shy away from collaborations in the diabetes space. After all, the Abbott Park, IL-based company teamed up with rival Medtronic to develop a continuous glucose ...

Forbes contributors publish independent expert analyses and insights. Bruce Japsen writes about healthcare business and policy. Abbott Laboratories $21 billion deal to acquire cancer test maker Exact ...

Many medtech companies are cutting guidance because of the tariff situation, but Abbott Laboratories isn’t one of them. The Abbott Park, IL-based company was a beacon of hope to both investors and ...

Add Yahoo as a preferred source to see more of our stories on Google. A federal judge handed Abbott Laboratories another win this week in its yearslong battle over the safety of its formulas for ...

Abbott has been hit with a slew of complaints from the FDA in a warning letter related to its continuous glucose monitor (CGM) franchise, FreeStyle Libre. Last October, an agency inspection of ...